Evidence map›Paper›PMID 35019681›Full record

ArticleMicrobiology spectrum2022

Development of Droplet Digital PCR-Based Assays to Quantify HIV Proviral and Integrated DNA in Brain Tissues from Viremic Individuals with Encephalitis and Virally Suppressed Aviremic Individuals.

Hye Kyung Chung, Julian B Hattler, Jigna Narola, Harita Babbar, Yanhui Cai, Mohamed Abdel-Mohsen, Woong-Ki Kim

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hye Kyung ChungAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Julian B HattlerDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical Schoolgrid.255414.3, Norfolk, Virginia, USA.
Jigna NarolaAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Harita BabbarAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Yanhui CaiThe Wistar Institute, Philadelphia, Pennsylvania, USA.
Mohamed Abdel-MohsenThe Wistar Institute, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9945-4314
Woong-Ki KimDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical Schoolgrid.255414.3, Norfolk, Virginia, USA.ORCID 0000-0001-9964-185X
BioScience Laboratories (United States) · USEastern Virginia Medical School · USThe Wistar Institute · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
Targeting Brain Macrophage Reservoirs of SIV during HAARTR01MH107333 · NIMH · EASTERN VIRGINIA MEDICAL SCHOOL · PI KIM, WOONG-KI · 2015 to 2019
$3.4M
NIAID NIH HHS P30 AI045008NIMH NIH HHS R01 MH107333NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

Although combination antiretroviral therapy (cART) can suppress the replication of HIV, the virus persists and rebounds when treatment is stopped. To find a cure that can eradicate latent reservoir, a method should be able to quantify the lingering HIV. Unlike other digital PCR technologies, droplet digital PCR (ddPCR), provides absolute quantification of target DNA molecules using fluorescent dually labeled probes by massively partitioning the sample into droplets. ddPCR enables exquisitely sensitive detection and quantification of viral DNA from very limiting clinical samples, including brain tissues. We developed and optimized duplex ddPCR assays for the detection and quantification of HIV proviral DNA and integrated DNA in the brain of HIV-1-infected patients. We have applied these approaches to successfully analyze 77 human brain tissues obtained from 27 HIV-1-infected individuals, either fully virally suppressed or with encephalitis, and were able to quantify low levels of viral DNA. Further developments and advancement of digital PCR technology is promising to aid in accurate quantification and characterization of the persistent HIV reservoir.

Indexed as

BrainDNA, ViralEncephalitisHIV-1HIV InfectionsHumansPolymerase Chain ReactionProvirusesViral LoadViremiaVirus IntegrationDNA, Viralantiretroviral therapybraindroplet digital PCRHIV-1HIV-associated neurocognitive disordersreservoir

Identifiers

PMID35019681
PMCPMC8754137
OpenAlexW4205087199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.